Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL320219

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
O=C1N(Cc2ccc3[nH]cnc3c2)[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N1Cc1ccc2[nH]cnc2c1

Basic Information

ChEMBL ID CHEMBL320219
Phase Preclinical
Structure Type MOL
InChI Key ZBEZQMBJHMGCQR-WZJLIZBTSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names

Molecular Properties

586.7
MW (Da)
4.82
ALogP
5
HBA
4
HBD
121.4
PSA (Ų)
0.20
QED
1
Ro5 Violations
8
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C35H34N6O3
MW 586.70
Aromatic Rings 6
Heavy Atoms 44
NP-Likeness -0.27

Activity Summary

Ki 1 meas. best 7.96

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Human immunodeficiency virus type 1 protease
CHEMBL243
Ki 7.96 7.96 11.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Human immunodeficiency virus type 1 protease Ki = 11.0 nM 7.96 Inhibitory activity was evaluated against HIV protease -

Literature References

PubMed DOI Target Context # Activities
- 10.1016/S0960-894X(96)00531-8 Human immunodeficiency virus type 1 protease 3
- 10.1016/S0960-894X(96)00531-8 No relevant target 1

Data from ChEMBL 36 via Core Engine